Investigating the Impact of GLP-1 Receptor Agonist-Induced Fat Loss on Collagen Synthesis and Skin Elasticity

Abstract

The increasing use of glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide, for weight management has sparked interest in understanding their broader physiological effects, particularly on skin health. GLP-1 receptor agonists are effective at inducing fat loss in patients with obesity and type 2 diabetes, but their influence on collagen synthesis and skin elasticity remains underexplored. This literature review investigates the effects of fat loss induced by GLP-1 receptor agonists on dermal health, with a focus on collagen turnover and the skin’s ability to maintain elasticity. Collagen, a critical structural protein, is essential for skin strength, elasticity, and overall integrity. The mechanical properties of skin can be altered by fat loss, which raises questions about the balance between weight reduction and skin health during GLP-1 receptor agonist treatment. This review synthesizes findings from studies examining the role of fat loss on collagen production and skin elasticity, including clinical trials, animal models, and in vitro experiments. Comparative data from other weight loss interventions, such as bariatric surgery and lifestyle changes, are also considered to provide a broader context for understanding how GLP-1 receptor agonists influence dermal fibroblasts, collagen synthesis, and the development of skin sagging or laxity. We highlight gaps in the current literature and propose potential mechanisms by which GLP-1 receptor agonists might modulate collagen turnover, skin aging, and dermal elasticity, offering new insights into the broader effects of these medications.